Boberg KM - Search Results

1

Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.

Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Boberg KM, et al. Scand J Gastroenterol. 1998 Jan;33(1):99-103. doi: 10.1080/00365529850166284. Scand J Gastroenterol. 1998. PMID: 9489916

2

Etiology and pathogenesis in primary sclerosing cholangitis.

Boberg KM, Lundin KE, Schrumpf E. Boberg KM, et al. Scand J Gastroenterol Suppl. 1994;204:47-58. doi: 10.3109/00365529409103625. Scand J Gastroenterol Suppl. 1994. PMID: 7824878 Review.

3

Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis.

Boberg KM, Schrumpf E, Fausa O, Elgjo K, Kolmannskog F, Haaland T, Holter E. Boberg KM, et al. Scand J Gastroenterol. 1994 Aug;29(8):744-52. doi: 10.3109/00365529409092504. Scand J Gastroenterol. 1994. PMID: 7973436

4

Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis.

Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, Schrumpf E. Boberg KM, et al. Hepatology. 1996 Jun;23(6):1369-76. doi: 10.1002/hep.510230612. Hepatology. 1996. PMID: 8675153

5

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.

Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, Knutsen I, Pares A, Rosina F, Olerup O, Thorsby E, Schrumpf E. Spurkland A, et al. Among authors: boberg km. Tissue Antigens. 1999 May;53(5):459-69. doi: 10.1034/j.1399-0039.1999.530502.x. Tissue Antigens. 1999. PMID: 10372541

6

Severe liver failure in exertional heat stroke.

Giercksky T, Boberg KM, Farstad IN, Halvorsen S, Schrumpf E. Giercksky T, et al. Among authors: boberg km. Scand J Gastroenterol. 1999 Aug;34(8):824-7. doi: 10.1080/003655299750025778. Scand J Gastroenterol. 1999. PMID: 10499485

7

Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.

Boberg KM, Schrumpf E, Bergquist A, Broomé U, Pares A, Remotti H, Schjölberg A, Spurkland A, Clausen OP. Boberg KM, et al. J Hepatol. 2000 Mar;32(3):374-80. doi: 10.1016/s0168-8278(00)80386-4. J Hepatol. 2000. PMID: 10735605

8

Primary sclerosing cholangitis: challenges of a new millenium.

Schrumpf E, Boberg KM. Schrumpf E, et al. Among authors: boberg km. Dig Liver Dis. 2000 Dec;32(9):753-5. doi: 10.1016/s1590-8658(00)80350-3. Dig Liver Dis. 2000. PMID: 11215553 Review. No abstract available.

9

Epidemiology of primary sclerosing cholangitis.

Schrumpf E, Boberg KM. Schrumpf E, et al. Among authors: boberg km. Best Pract Res Clin Gastroenterol. 2001 Aug;15(4):553-62. doi: 10.1053/bega.2001.0204. Best Pract Res Clin Gastroenterol. 2001. PMID: 11492967 Review.

10

The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.

Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, Broomé U, Chapman R, Olerup O, Pares A, Rosina F, Schrumpf E. Boberg KM, et al. Scand J Gastroenterol. 2001 Aug;36(8):886-90. doi: 10.1080/003655201750313441. Scand J Gastroenterol. 2001. PMID: 11495087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters